Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-01-20A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas
-
CLINICAL_TRIALS study record update · 2016-01-14Phase II Multicenter Study of the Combination of Weekly Carboplatin and Paclitaxel as First-line Chemotherapy for Elderly Patients With Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2016-01-14Phase II Study With Capecitabine as Monotherapy in the Treatment of Platinum Resistant or Refractory Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2015-12-28Spectroscopy With Surface Coils and Decoupling
-
CLINICAL_TRIALS study record update · 2015-12-23Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-12-23A Randomized Phase III Study Comparing Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Epithelial Ovarian Carcinoma Who Failed First-Line Platinum-Based Therapy
-
CLINICAL_TRIALS study record update · 2015-12-23A Phase II Study Of Paclitaxel, Carboplatin And Gemcitabine In Previously Untreated Patients With Epithelial Ovarian Carcinoma FIGO Stage IIB-IV
-
CLINICAL_TRIALS study record update · 2015-12-23Phase I/II BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients in First or Second Relapse
-
CLINICAL_TRIALS study record update · 2015-12-10Orthotopic Propagation of Primary Human Ovarian Tumors for Preclinical Investigation of Novel Anti-Tumor Agents.
-
CLINICAL_TRIALS study record update · 2015-12-09Phase 1b/2, Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors, Multiple Myeloma or Lymphoma
-
CLINICAL_TRIALS study record update · 2015-12-03Phase I Dose Escalation Trial of Biweekly Alimta (With Vitamin Supplementation) in Combination With Taxotere in Advanced Solid Tumor Patients
-
CLINICAL_TRIALS study record update · 2015-11-26Sexual Functioning After Primary Treatment of Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-11-25Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-11-06Integration of Palliative Care in Use of Intra-Peritoneal Chemotherapy for Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-10-27A Phase II Study of Sunitinib in Patients With Refractory or Relapsed Germ Cell Tumors
-
CLINICAL_TRIALS study record update · 2015-10-26A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy
-
CLINICAL_TRIALS study record update · 2015-10-20A Two-part Phase 1/2a, Open-label, Dose Escalation Study to Evaluate the Tolerability and Preliminary Antitumour Activity of OPB-111001 in Patients With Advanced Cancers That Are Poorly Responsive to Standard Anticancer Treatment
-
CLINICAL_TRIALS study record update · 2015-10-19Phase II Study of Irinotecan in Combination With Bevacizumab for the Treatment of Recurrent Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2015-10-14A Phase 1b Open-Label, Multi-Center Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With High-Risk Stage I and Stages II-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
-
CLINICAL_TRIALS study record update · 2015-10-12Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-10-09Improving the Quality of Advanced Cancer Care With Disease Management
-
CLINICAL_TRIALS study record update · 2015-10-08A Randomized, Double Blind, Placebo-Controlled Trial of Celecoxib in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2015-10-07The Elizabeth Registry for Low Grade Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-29A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2015-09-28A Multicenter Randomized Phase II Study of Docetaxel/Carboplatin Versus Docetaxel/Pegylated Liposomal Doxorubicin as Second Line Treatment in Patients With Platinum Sensitive Disease